What blood tests are recommended for patients presenting with Raynaud's phenomenon?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Tests for Raynaud's Phenomenon

For patients presenting with Raynaud's phenomenon, the essential blood tests include complete blood count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), antinuclear antibody (ANA), and biochemical profile to distinguish primary from secondary Raynaud's and identify underlying connective tissue diseases. 1

Core Laboratory Panel

The initial laboratory evaluation should include:

  • Complete blood count (CBC) with platelet count to detect anemia, thrombocytosis, or other hematologic abnormalities 2, 1
  • Erythrocyte sedimentation rate (ESR) - normal in primary Raynaud's but elevated in secondary forms, particularly with connective tissue diseases 2, 3, 4
  • C-reactive protein (CRP) to assess for inflammatory conditions 1
  • Antinuclear antibody (ANA) - the most critical screening test, as positive results suggest underlying connective tissue disease 2, 1, 3
  • Biochemical profile including renal and hepatic function 1
  • Thyroid function tests to exclude thyroid-related causes 1

Specialized Autoimmune Testing

When ANA is positive or clinical suspicion for connective tissue disease is high:

  • Rheumatoid factor to evaluate for rheumatoid arthritis 2
  • Anticentromere antibodies - highly specific for limited systemic sclerosis 4
  • Anti-topoisomerase (Scl-70) antibodies - associated with diffuse systemic sclerosis 4
  • Anti-U1-RNP antibodies - elevated in mixed connective tissue disease 4
  • Lupus erythematosus test for systemic lupus erythematosus 2

Prothrombotic and Vascular Workup

For patients with severe symptoms, digital ulcers, or asymmetric presentation:

  • Lupus anticoagulant to detect antiphospholipid syndrome 5
  • Anticardiolipin antibodies (IgG and IgM) 5
  • Protein C, protein S, and antithrombin III levels to identify clotting system abnormalities 5
  • Factor V Leiden and prothrombin mutations in selected cases with thrombotic history 5
  • Homocysteine level to detect hyperhomocysteinemia 5

Additional Testing Based on Clinical Context

  • Protein electrophoresis to exclude paraproteinemia or cryoglobulinemia 1
  • Hepatitis B and C serology when cryoglobulinemia is suspected 1
  • HIV testing if risk factors present 5

Key Diagnostic Distinctions

Primary Raynaud's typically shows completely normal laboratory results - normal ESR, negative ANA, and normal CBC. 3, 4 This benign form usually begins at puberty, predominantly affects women, and has symmetric involvement of multiple digits. 4

Secondary Raynaud's demonstrates abnormal laboratory findings - elevated ESR, positive ANA (often with specific autoantibodies), and may show anemia or thrombocytosis. 3, 4 This form tends to begin later in life, causes more severe ischemia with potential for digital ulcers or gangrene, and is most commonly associated with systemic sclerosis. 5, 6

Critical Pitfalls to Avoid

Do not rely solely on laboratory tests - nailfold capillaroscopy is essential and can detect systemic sclerosis years before other manifestations appear. 1, 3 Normal capillaroscopy with negative ANA strongly suggests primary Raynaud's, while abnormal capillaroscopy (enlarged capillaries, hemorrhages, avascular areas) indicates secondary disease even if other tests are initially normal. 3, 4

Timing matters - blood samples should be collected before initiating any immunosuppressive therapy to avoid false-negative results. 7 Additionally, acute stress, inflammation, or pregnancy can falsely elevate certain markers. 8

Age and presentation guide testing intensity - older age at onset (>30 years), unilateral or asymmetric involvement, severe painful episodes, digital ulceration, or systemic symptoms (joint pain, skin changes, dysphagia) warrant comprehensive autoimmune and prothrombotic evaluation. 5, 6

References

Research

Recent advances in the workup and management of Raynaud phenomenon.

Polish archives of internal medicine, 2019

Research

[Raynaud's phenomenon].

Revue medicale de Liege, 2004

Guideline

Causes and Clinical Features of Raynaud's Phenomenon

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Autoimmune Encephalitis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.